Skystar Bio-Pharmaceutical Company financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2013-12-31 3 months ending 2013-09-30 3 months ending 2013-06-30 3 months ending 2013-03-31 3 months ending 2012-12-31
Revenue 9.63 15.99 11.34 5.53 7.86
Other Revenue, Total - - - - -
Total Revenue 9.63 15.99 11.34 5.53 7.86
Cost of Revenue, Total 4.91 7.78 5.38 2.93 4.03
Gross Profit 4.72 8.21 5.96 2.60 3.82
Selling/General/Admin. Expenses, Total 1.52 3.15 1.32 1.53 2.05
Research & Development 0.54 0.32 0.09 0.00 1.62
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) - - - - -
Other Operating Expenses, Total - - - - -
Total Operating Expense 6.97 11.25 6.79 4.46 7.70
Operating Income 2.66 4.74 4.55 1.07 0.15
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net 0.02 0.03 0.00 0.00 0.40
Income Before Tax 2.93 4.52 4.45 1.03 0.28
Income After Tax 2.33 3.73 3.75 0.71 -0.12
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items 2.33 3.73 3.75 0.71 -0.12
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income 2.33 3.73 3.75 0.71 -0.12
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items 2.33 3.73 3.75 0.71 -0.12
Income Available to Common Incl. Extra Items 2.33 3.73 3.75 0.71 -0.12
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment - 0.00 0.00 - -
Diluted Weighted Average Shares 7.78 7.62 7.62 7.61 7.61
Diluted EPS Excluding Extraordinary Items 0.30 0.49 0.49 0.09 -0.02
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue - 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS 0.30 0.49 0.49 0.09 -0.02